肝硬化患者肝细胞癌监测模式与结局
该回顾性队列研究纳入2008年1月至2022年12月在美国2个大型医疗系统诊断的2028例肝细胞癌患者,分析诊断前一年内的影像监测模式及其与早期检出、治愈性治疗和总生存的关系。结果显示监测模式差异大,CT/MRI和超声联合甲胎蛋白与早期检出相关,而单用超声未显示关联。
要点
- 2028例肝细胞癌患者中,34.8%诊断前一年内无肝脏影像监测。
- CT/MRI和超声联合甲胎蛋白与早期检出和治愈性治疗相关,单用超声未显示关联。
- 研究期间无影像监测比例稳定,而CT/MRI使用增加。
核心结论
- 肝细胞癌监测模式在临床实践中存在差异,并与不同临床结局相关。
- 在等待数据确定CT或MRI监测在特定患者中能否以成本效益方式实施期间,甲胎蛋白对基于超声的监测具有补充作用,支持将其纳入实践指南。
研究设计与样本
- 回顾性队列研究,纳入2008年1月至2022年12月在美国2个大型医疗系统诊断的2028例肝细胞癌患者。
- 记录诊断前一年内的影像接受情况:超声联合甲胎蛋白、单用超声、多期增强CT/MRI及无肝脏影像。
- 采用多变量逻辑回归和Cox回归分析比较各监测策略间的早期肿瘤检出、治愈性治疗接受和总生存。
主要发现
- 2028例患者中46.7%为巴塞罗那临床肝癌分期A期;703例(34.7%)接受超声联合甲胎蛋白,293例(14.5%)单用超声,326例(16.1%)接受多期CT/MRI,706例(34.8%)诊断前一年内无影像。
- 研究期间无影像监测比例稳定,而CT/MRI使用增加。
- 与无影像相比,CT/MRI和超声联合甲胎蛋白与早期肝细胞癌检出和治愈性治疗相关,单用超声未显示关联。
- 与单用超声相比,CT/MRI和超声联合甲胎蛋白与早期检出增加相关。
临床怎么用
- 原文结论指出甲胎蛋白对基于超声的监测具有补充作用,支持将其纳入实践指南。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) surveillance is associated with improved early detection and reduced mortality, although practice patterns and effectiveness vary in clinical practice. We aimed to characterize HCC surveillance patterns in a large, diverse cohort of patients with HCC. METHODS: We conducted a retrospective cohort study of patients diagnosed with HCC between January 2008 and December 2022 at 2 large US health systems. We recorded imaging receipt in the year before HCC diagnosis: ultrasound plus α-fetoprotein (AFP), ultrasound alone, multiphasic contrast-enhanced computed tomography (CT)/magnetic resonance imaging (MRI), and no liver imaging. We used multivariable logistic and Cox regression analysis to compare early tumor detection, curative treatment receipt, and overall survival between surveillance strategies. RESULTS: Among 2028 patients with HCC (46.7% Barcelona Clinic Liver Cancer stage A), 703 (34.7%) had ultrasound plus AFP, 293 (14.5%) had ultrasound alone, 326 (16.1%) had multiphasic CT/MRI, and 706 (34.8%) had no imaging in the year before HCC diagnosis. Over the study period, proportions without imaging were stable, whereas use of CT/MRI increased. Compared with no imaging, CT/MRI and ultrasound plus AFP, but not ultrasound alone, were associated with early stage HCC detection and curative treatment. Compared with ultrasound alone, CT/MRI and ultrasound plus AFP were associated with increased early stage detection. CONCLUSIONS: HCC surveillance patterns vary in clinical practice and are associated with differing clinical outcomes. While awaiting data to determine if CT or MRI surveillance can be performed in a cost-effective manner in selected patients, AFP has a complementary role to ultrasound-based surveillance, supporting its adoption in practice guidelines.
引用
- Daher D, Seif El Dahan K, Cano A, et al. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023. PMID: 37573986. doi:10.1016/j.cgh.2023.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。